We are live on ! Find out more
AVIR icon

Atea Pharmaceuticals
AVIR

81 hedge funds and large institutions have $3.04B invested in Atea Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

83% more call options, than puts

Call options by funds: $2.04M | Put options by funds: $1.12M

47% more capital invested

Capital invested by funds: $2.07B → $3.04B (+$970M)

17% more funds holding

Funds holding: 69 → 81 (+12)

0% more funds holding in top 10

Funds holding in top 10: 9 → 9 (0)

0.57% less ownership

Funds ownership: 60.41% → 59.84% (-0.57%)

4% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 25

Holders
81
Holders Change
+12
Holders Change %
+17.39%
% of All Funds
1.42%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
19
Increased
24
Reduced
25
Closed
7
Calls
$2.04M
Puts
$1.12M
Net Calls
+$925K
Net Calls Change
+$925K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$291M
2
Bank Julius Baer & Co
Bank Julius Baer & Co
Switzerland
+$5.25M
3
Prudential Financial
Prudential Financial
New Jersey
+$4.76M
4
State Street
State Street
Massachusetts
+$4.18M
5
E
Ergoteles
New York
+$3.4M

Top Sellers

Rank Fund Capital Flow
1
AICPI
ABG Innovation Capital Partners III
Hong Kong
-$110M
2
RG
Redmile Group
California
-$72.5M
3
BCPEMI
Bain Capital Public Equity Management II
Massachusetts
-$16.9M
4
BlackRock
BlackRock
New York
-$16.2M
5
Citadel Advisors
Citadel Advisors
Florida
-$11.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMU
26
Pictet Asset Management (UK)
United Kingdom
$4.66M -$5.21M -77,044 -51%
Prudential Financial
27
Prudential Financial
New Jersey
$4.35M +$4.76M +70,435 New
Ameriprise
28
Ameriprise
Minnesota
$3.85M -$3.3M -48,811 -44%
Morgan Stanley
29
Morgan Stanley
New York
$3.6M -$3.26M -48,266 -45%
N
30
Nuveen
North Carolina
$3.41M +$143K +2,122 +4%
E
31
Ergoteles
New York
$3.11M +$3.4M +50,362 New
LCM
32
Laurion Capital Management
New York
$2.78M – – –
Bank of New York Mellon
33
Bank of New York Mellon
New York
$2.73M +$501K +7,418 +20%
Wellington Management Group
34
Wellington Management Group
Massachusetts
$2.62M -$23.6K -349 -0.8%
CAM
35
Congress Asset Management
Massachusetts
$2.49M +$498K +7,365 +22%
Millennium Management
36
Millennium Management
New York
$2M +$2.19M +32,420 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$1.74M +$1.9M +28,187 New
Schroder Investment Management Group
38
Schroder Investment Management Group
United Kingdom
$1.69M +$1.85M +27,325 New
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$1.61M -$165K -2,441 -9%
TD Asset Management
40
TD Asset Management
Ontario, Canada
$1.54M +$290K +4,298 +21%
Bank of America
41
Bank of America
North Carolina
$1.5M +$684K +10,118 +71%
EMG
42
ETF Managers Group
New Jersey
$1.42M -$894K -13,231 -34%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.36M +$6.15K +91 +0.4%
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$1.24M – – –
AllianceBernstein
45
AllianceBernstein
Tennessee
$1.16M +$412K +6,102 +48%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$1.06M +$314K +4,647 +37%
AC
47
Athanor Capital
New York
$933K -$121K -1,787 -11%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$852K +$169K +2,500 +22%
Deutsche Bank
49
Deutsche Bank
Germany
$600K -$59.8K -885 -8%
William Blair & Company
50
William Blair & Company
Illinois
$555K +$247K +3,650 +68%
1
2
3 4

AVIR Hedge Fund Activity: Q1 2021 in Review

81 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Atea Pharmaceuticals (AVIR) for Q1 2021, worth a combined $3.04B — up 47% from $2.07B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new AVIR positions and 7 closed out — a net gain of 12 holders — while 24 added to existing stakes and 25 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $291M. The largest seller was ABG Innovation Capital Partners III, exiting entirely with an estimated $110M sold.

  • 81 institutional investors held Atea Pharmaceuticals (AVIR) as of Q1 2021, up from 69 in Q4 2020.
  • Funds reported $3.04B of Atea Pharmaceuticals stock for Q1 2021, up 47% quarter-over-quarter.
  • 19 funds opened new Atea Pharmaceuticals positions in Q1 2021 and 7 closed out, a net change of +12 holders.
  • The largest Atea Pharmaceuticals buyer in Q1 2021 was Fidelity Investments, an estimated $291M added.
  • The largest Atea Pharmaceuticals seller in Q1 2021 was ABG Innovation Capital Partners III, an estimated $110M sold.

Based on aggregated 13F filings for Q1 2021.